NCT01824225已完成4 期
Study of PRN and Every 2months Intravitreal Aflibercept After 3 Initial Monthly Injection for Age Related Macular Degeneration
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Visual acuity after treatment by PRN or 2 months intravitreal Aflibercept
研究概览
简要总结
Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of age-related macular degeneration
排除标准
- •Any treatment before intravitreal Aflibercept for age-related macular degeneration.
- •Visual acuity above 0.1 in decimal visual acuity
研究组 & 干预措施
PRN injection of aflibercept
Active Comparator
Intravitreal aflibercept
干预措施: Aflibercept (Drug)
Two months injection of aflibercept
Active Comparator
Intravitreal afilibercept
干预措施: Aflibercept (Drug)
结局指标
主要结局
Visual acuity after treatment by PRN or 2 months intravitreal Aflibercept
时间窗: one year
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
4 期
Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly AfliberceptNeovascular Age-related Macular DegenerationNCT03468296Tennessee Retina22
已完成
4 期
Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.Macular DegenerationNCT01831947Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH40
Unknown
4 期
Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910Exudative Age-related Macular DegenerationNCT01961414Palmetto Retina Center, LLC45
已完成
4 期
Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein OcclusionBranch Retinal Vein OcclusionNCT02478515Nagoya City University27
已完成
不适用
Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact LensesMyopiaHyperopiaNCT05656885Coopervision, Inc.40